A Singularity in Stem Cell Research and Human Cloning

S. Niggol Seo

Chapter Chapter 7 in The Economics of Singularities of Science Elucidated with Buddhist Thoughts, 2024, pp 139-157 from Springer

Abstract: Abstract This chapter provides an analysis of a singularity from stem cell research. The topics covered include stem cell research, regenerative medicine, animal cloning, genetically modified organisms, and gene therapies. A singularity from stem cell research can be defined from a human cloning possibility or correlated risks with stem cell-generated organs. It may be indefensible to rely on stem cells obtained from embryos, but scientists may be able to obtain pluripotent stem cells from gene reprogramming. The economic value of stem cell research as well as gene therapies may be exceptionally high. From the Buddhist standpoint, there is little reason to pursue a human cloning while it is likely irrational to pursue to replace all of your internal organs to extend your life a little bit. This analysis is applicable to a range of gene alteration sciences.

Keywords: Singularity; Stem cell research; Embryonic stem cell; Gene reprogramming; Pluripotent; Buddhist standpoint; Gene therapy; Animal cloning; Genetically modified organisms (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-69118-8_7

Ordering information: This item can be ordered from
http://www.springer.com/9783031691188

DOI: 10.1007/978-3-031-69118-8_7

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().